after 48 h. Isolates were classified as S, S-DD or R according to the NCCLS guidelines. 5 Fluconazole MICs obtained with the modified BMD tests and Etest read at 24 and 48 h were compared with the reference BMD MICs read at 48 h. Discrepancies between MICs of no more than ±1 dilution were used to calculate the percentage of agreement. Categorical agreement was defined when the applied method gave the same category result compared with the reference BMD category read at 48 h.
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4. Swoboda-Kopec, E., Kawecki, D., Wroblewska, M. et al. (2003) . Epidemiology and susceptibility to antifungal agents of fungi isolated from clinical specimens from patients hospitalized in the Department of General and Liver Surgery of the Medical University of Warsaw. The aim of this study was to evaluate the potency of LBM415 against key Gram-positive pathogens, as well as Haemophilus influenzae, from Japan where antimicrobial resistance levels are very high among clinically significant Gram-positive organisms and community-acquired respiratory pathogens. 6, 7 A total of 695 clinical isolates originally collected in Japan included Staphylococcus aureus (n = 222), Haemophilus influenzae (n = 119), Streptococcus pneumoniae (n = 122), coagulasenegative staphylococci (CoNS; n = 119), Enterococcus spp. (n = 65) and Streptococcus spp. (n = 48). No vancomycin-resistant enterococci were detected during this period. LBM415 (Novartis Pharmaceuticals, Basel, Switzerland) was diluted in broth microdilution trays or agar using NCCLS methods and media supplements as required.
8 NCCLS quality control strains with established MIC ranges were included throughout the study.
The MIC distribution, MIC 50 and MIC 90 values are shown in Table 1 . Oxacillin-resistant S. aureus had slightly lower LBM415 MIC values than oxacillin-susceptible strains. MIC 50 and MIC 90 values for LBM415 against oxacillin-resistant S. aureus were 2 log 10 dilutions lower than those observed by Credito et al., 2 although they tested a smaller number of strains. CoNS had similar MIC results to S. aureus, although oxacillin-resistant strains appeared to be less susceptible than oxacillin-susceptible strains. All enterococci were inhibited at < _ 8 mg/L of LBM415. All S. pneumoniae were inhibited at < _ 2 mg/L of the PDF inhibitor, regardless of penicillin or multi-drug resistance (MDR). Similar results have been shown by Ednie et al. 3 The LBM415 MIC 90 for the b-haemolytic streptococci was 0.5 mg/L; all streptococci were inhibited at < _ 4 mg/L. Japan has the highest incidences of b-lactamase-negative ampicillin-resistant H. influenzae (BLNAR) in the world. 9 It is of interest that, although the MIC 90 for b-lactamase-negative ampicillin-susceptible (BLNAS) strains was 8 mg/L, 28% of the BLNAR isolates tested had LBM415 MIC results at >8 mg/L, and the MIC 90 was four-fold higher. This finding may limit the PDF inhibitor effectiveness against H. influenzae in Japan.
The in vitro spectrum of LBM415 was similar to that of other recently published PDF inhibitor agents, such as BB-83698, BB-81384 and others with predominant Gram-positive activity. 10, 11 LBM415 has greater in vitro activity against H. influenzae.
This study indicates that LBM415 appears to be an active agent that may be suitable for the treatment of infections caused by Gram-positive organisms, including oxacillin-resistant staphylococci and MDR S. pneumoniae, but with lower activity against H. influenzae. Sir, Enterococcus spp. are commensal bacteria of the intestinal microbiota in humans and animals, but over the last decade have also been considered as important nosocomial pathogens. The emergence of vancomycin-resistant enterococci (VRE) in Europe has been associated with the use of avoparcin as a growth promoter in food animals, 1 until its ban in 1997 by the EU. There are reports of VRE in farm animals in different countries, including in Portugal, 1 -4 but fewer studies have addressed the occurrence of VRE in pets or wild animals.
2,4 -6 VRE have not previously been detected in pets or in wild animals in Portugal, but the prevalence of vancomycin-resistant Enterococcus faecium in some Portuguese hospitals seems to be relatively high.
7
The aim of this study was to analyse the level of faecal colonization by vanA-containing enterococci in healthy pets, poultry and wild animals as well as in healthy humans in Portugal, 7 years after the banning of avoparcin use.
The presence of faecal VRE was investigated in 292 faecal samples recovered from healthy humans (n = 73), healthy pets (39 dogs and 32 cats), poultry (n = 76) and wild animals (n = 72; including 12 birds of prey, nine owls, six foxes, six wild rabbits, four European genets, four forest wildcats, four salamanders, three storks, three magpies, three deer, three vipers, two wolves, two otters, two partridges, two badgers, one mouflon, one hedgehog, one pigeon, one ferret, one tortoise, one quail and one wild boar). Faecal samples from healthy pets and humans were collected during 2003 (one sample per individual, none of whom had been administered antibiotics in the previous 4 months). Pet samples were obtained in rural and urban areas from different veterinarian clinics (n = 37), or from pets in people's homes (n = 34). Poultry samples were collected during February -June 2004 in a slaughterhouse located in Northern Portugal; each sample corresponded to a different flock. Faecal samples from wild animals were collected during 2003 -2004 , and most of them were obtained in the Pêneda Gêres Natural Park and the rest from other natural areas of Portugal.
Faecal samples were diluted and sampled in Slanetz-Bartley agar plates supplemented with 4 mg/L vancomycin and were incubated for 48 h at 358C. Colonies with typical enterococcal morphology were identified by biochemical tests and specific PCR for the different enterococcal species. 4 Antibiotic susceptibility was tested for 11 antibiotics (vancomycin, teicoplanin, ampicillin, streptomycin, gentamicin, kanamycin, chloramphenicol, tetracycline, erythromycin, quinupristin/dalfopristin and ciprofloxacin) by the NCCLS disc diffusion method and, for vancomycin and teicoplanin, also by the NCCLS agar dilution method. High-level resistance was considered for aminoglycosides. Vancomycin resistance genes (vanA, vanB, vanC-1, vanC-2/3 and vanD) were sought by PCR in all isolates that showed resistance or reduced susceptibility to glycopeptides. 4 Resistance genes for other antibiotics, including tet(M), tet(K), tet(L), erm(A), erm(B), erm(C), aph(3 0 )-IIIa, ant(6)-Ia and catA were also sought by PCR. 4 vanA-containing enterococci were detected in seven of 76 poultry samples (9.2%), in one dog of the 71 pet samples (1.4%) and in two of 73 human samples (2.7%). No vanA-containing enterococci were detected in the faecal samples of wild animals. Four of the VanA enterococci were identified as E. faecium (three from poultry, and the dog isolate), three as Enterococcus durans (from poultry) and three as Enterococcus hirae (one from poultry and two from humans). The characteristics of these strains and of the animals from which they were recovered are shown in Table 1 . All vanA isolates showed high-level vancomycin (MIC > _ 128 mg/L) and teicoplanin (MIC 16-64 mg/L) resistance; they were also resistant to tetracycline (n = 10), and some also to erythromycin (n = 7), high-level kanamycin (n = 4), highlevel streptomycin (n = 2), and ampicillin and ciprofloxacin (n = 1). The tet(M) gene, related to tetracycline resistance, was found in all 10 vanA isolates, in all of the cases associated with tet(L) ( Table 1) ; erm(B) was demonstrated in the seven erythromycin-resistant vanA isolates; aph(3 0 )-IIIa in the four that showed high-level kanamycin resistance; and ant(6)-Ia in the two that showed high-level streptomycin resistance. We were interested to discover the wide pattern of antibiotic resistance of the vanA-containing E. faecium strain recovered from a dog,
